Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$256,717
+$44,854 QoQ
Shares Held
95,434
0.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 130 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. OVID ranks #71 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
552,566 | $13,372,097 | |
| 2 | INVA |
Innoviva, Inc.
|
350,253 | $7,954,245 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
791,616 | $6,420,005 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
124,184 | $4,858,078 | |
| 5 | EXEL |
Exelixis, Inc.
|
66,100 | $3,596,501 | |
| 6 | CRMD |
CorMedix Inc.
|
434,132 | $3,407,936 | |
| 7 | KROS |
Keros Therapeutics, Inc.
|
265,017 | $2,835,681 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,794,540 |
All Filings in OVID
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,717 | 95,434 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $211,863 | 95,434 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $155,557 | 95,434 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $124,064 | 95,434 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,493 | 95,434 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,775 | 95,434 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $213,993 | 229,115 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $365,257 | 309,540 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $270,818 | 352,170 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,091,503 | 357,870 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,414,690 | 439,345 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,761,408 | 458,700 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,627,778 | 801,152 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,135,156 | 827,580 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,694,832 | 911,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,671,640 | 908,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,114,955 | 983,700 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,155,834 | 368,100 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $678,594 | 211,400 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $710,304 | 211,400 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $826,574 | 211,400 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $922,188 | 229,400 | Shares | Sole | 2021-05-17 | |
| 2020-03-31 | $722,948 | 242,600 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||